ZEISS Vision

And that’s a wrap! 🎬 The ZEISS Convention 2025 in Dubai has come to a close. A day filled with inspiring talks on eye care, medical innovation, cinematography, AI, business development, and meaningful moments with our trusted partners and colleagues. Thank you to everyone who joined us and made this event truly special. Together, we continue to shape the future of vision. 💙

Today, on #WorldSightDay, we are focusing on lifelong visual health. 👁️🌍 Globally, at least 2.2 billion people are affected by near or distance vision impairment. In at least 1 billion of these cases, the impairment was preventable or remains unaddressed. The leading causes of vision impairment and blindness worldwide are refractive errors and cataracts. Despite the prevalence of these conditions globally, it is estimated that only 36% of people with a distance vision impairment due to refractive error and only 17% of people with vision impairment due to cataract have received appropriate intervention That’s why we are committed to making vision care accessible. 💙 Discover how we make it happen in the comments below! 👇 #LoveYourEyes #WSD2025

ZEISS Vision Care invests in Ocumeda | Underscoring our commitment to making eye and #VisionCare more accessible 🎯 Our investment in Ocumeda is part of our commitment to protect and improve the vision and visual health of consumers. We want to strengthen accessible eye and vision care – in Ocumeda we have found an excellent partner for this mission. A partner who shares our high standards in innovation and quality. Ocumeda already plays an important role as a future-proof platform provider for the ZEISS EyeCare Network, giving our customers the possibility to be successful in a business area with high potential and significant impact on consumers. Check the comments below to find out more. 👇

What if we could enable our customers to protect and improve the vision of even more children?💡 That’s one of the remarkable potentials of including #Orthokeratology into our portfolio. We are therefore delighted to announce that we have entered a definitive agreement to acquire 100% of the shares of Brighten Optix, a leading player in the field of orthokeratology and #SpecialtyContactLenses. 🔬👁️ Our acquisition of Brighten Optix will result in a strong addition to our already successful myopia management portfolio. Together, we will confront progressive myopia – one of the biggest vision care challenges we see in the world today. By complementing our #MyopiaManagement offerings with their proven and innovative portfolio of specialty contact lenses, we will empower our partners even more to protect and improve the vision of countless children. 🎯 Curious to learn more? Check the comments below to find out more. 👇

Thank you for visiting us at #ARVO2025 – it was a blast! 💥 We enjoyed a week filled with science, technology, and data that are redefining #Ophthalmology. Together with our colleagues from ZEISS Medical Technology, we showcased how the future of #EyeCare is here, highlighting the potential of AI for personalized discoveries and treatments. 🔬 We hope you enjoyed the show as much as we did! But remember, this is just the beginning of a revolution in clinical and research processes as we work to reshape how we preserve and enhance vision worldwide. 🌍 👀

The countdown to #ARVO2025 has begun! We’re proud to join our colleagues from ZEISS Medical Technology at booth #1729 in Salt Lake City — where AI, research, and clinical insights come together. Don’t miss our spotlight on myopia management in children and other exciting advancements from the ZEISS world of vision.

Is managing myopia new to you – or do you want to learn more? Expand your knowlege on myopia management with A to ZEISS insights available in our ZEISS Education Program. #ZEISSVision #ZEISSEducationProgram #ZEISSMyopiaManagement